By Josh White
Date: Thursday 25 Apr 2024
(Sharecast News) - Addiction treatment specialist Indivior reported double-digit net revenue growth for the first quarter on Thursday, with total net revenue rising 12% year-on-year to $284m, as it confirmed its intention to shift its primary listing to the United States.
By Iain Gilbert
Date: Thursday 29 Feb 2024
(Sharecast News) - Pharmaceuticals business Indivior has received final court approval for a landmark settlement in an antitrust multi-district litigation with the direct purchaser class.
By Josh White
Date: Thursday 22 Feb 2024
(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.
Currency | UK Pounds |
Share Price | 1,445.00p |
Change Today | 12.00p |
% Change | 0.84 % |
52 Week High | 1,885.00p |
52 Week Low | 1,135.00p |
Volume | 636,840 |
Shares Issued | 134.76m |
Market Cap | £1,947.26m |
RiskGrade | 314 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
No dividends found |
Time | Volume / Share Price |
17:08 | 500 @ 1,445.00p |
16:47 | 15,000 @ 1,445.33p |
16:41 | 23,150 @ 1,445.00p |
16:40 | 74,014 @ 1,443.95p |
16:35 | 314,212 @ 1,445.00p |
CEO | Mark Crossley |
Chair | Graham Hetherington |
You are here: research